Alpha DNA Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,556
| Closed | -$2.05M | – | 10 |
|
|
2024
Q4 | $2.05M | Sell |
11,556
-172
| -1% | -$30.6K | 0.78% | 21 |
|
|
2024
Q3 | $2.32M | Sell |
11,728
-5,821
| -33% | -$1.15M | 0.87% | 11 |
|
|
2024
Q2 | $3.01M | Buy |
17,549
+5,437
| +45% | +$933K | 1.17% | 6 |
|
|
2024
Q1 | $2.21M | Sell |
12,112
-6,210
| -34% | -$1.13M | 0.81% | 15 |
|
|
2023
Q4 | $2.84M | Buy |
18,322
+4,806
| +36% | +$745K | 1.11% | 10 |
|
|
2023
Q3 | $2.01M | Buy |
13,516
+158
| +1% | +$23.6K | 0.82% | 16 |
|
|
2023
Q2 | $1.8M | Buy |
13,358
+6,539
| +96% | +$881K | 0.6% | 30 |
|
|
2023
Q1 | $1.09M | Sell |
6,819
-3,847
| -36% | -$613K | 0.32% | 79 |
|
|
2022
Q4 | $1.72M | Buy |
10,666
+1,458
| +16% | +$236K | 0.61% | 21 |
|
|
2022
Q3 | $1.24M | Buy |
+9,208
| New | +$1.24M | 1.03% | 18 |
|
|
2021
Q2 | – | Sell |
-389
| Closed | -$42K | – | 102 |
|
|
2021
Q1 | $42K | Buy |
389
+76
| +24% | +$8.21K | 0.05% | 195 |
|
|
2020
Q4 | $33K | Buy |
+313
| New | +$33K | 0.04% | 210 |
|